Are Liquid Biopsy Tests Cost-Effective for CRC Screening?
In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.
Stay updated with breaking news from Chin Hur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
/PRNewswire/ -- Vivante Health, the leading provider of digital digestive health solutions for employers and health plans, today announced the addition of Dr....
Digital digestive healthcare company Vivante has added two gastroenterology specialists to its medical advisory board.
From science to engineering, writing to social sciences, here are the Columbians who received awards recently.